Further molecular and immunophenotypic analyses revealed that CD8-positive PD-1-positive TCI could predict the ICIs treatment response in pMMR colon cancer and was considered an effective predictor for ICIs therapy (21). Here, CD8A is linked to colonic neoplasm.